Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.
종목 코드 AORT
회사 이름Artivion Inc
상장일Feb 12, 1993
CEOMr. James Patrick (Pat) Mackin
직원 수1600
유형Ordinary Share
회계 연도 종료Feb 12
주소1655 Roberts Boulevard N W
도시KENNESAW
증권 거래소NYSE Consolidated
국가United States of America
우편 번호30144
전화17704193355
웹사이트https://artivion.com/
종목 코드 AORT
상장일Feb 12, 1993
CEOMr. James Patrick (Pat) Mackin
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음